Literature DB >> 30820558

Cultural adaptation and psychometric properties of the Chinese Burden of Treatment Questionnaire (C-TBQ) in primary care patients with multi-morbidity.

Weng Yee Chin1, Carlos King Ho Wong1, Cherry Cheuk Wai Ng2, Edmond Pui Hang Choi3, Cindy Lo Kuen Lam1.   

Abstract

BACKGROUND: The Burden of Treatment Questionnaire (TBQ) assesses the impact of a patient's treatment workload on their quality of life.
OBJECTIVES: The aim was to translate and validate the TBQ on Chinese primary care patients with multi-morbidity.
METHODS: The English TBQ was translated and back-translated using professional translators. Cognitive debriefing interviews were performed on 15 patients. The resulting instrument was tested on 200 primary care patients with multi-morbidity (>1 chronic disease) to examine its psychometric performance including exploratory factor analysis, confirmatory factor analysis, internal consistency and reliability. The EuroQol Five-Dimension Five-Level Questionnaire (EQ-5D-5L), Short-Form Six-Dimension (SF-6D), WONCA COOP Charts and the Global Health Rating Scale were used to assess convergent and divergent validity.
RESULTS: Median age of the respondents was 62 years (range 22-95 years) with a median of four conditions. The median TBQ total score was 16 (interquartile range 7.25-30). There was a significant floor effect (>15%) observed for all items. Spearman's correlations was >0.4 for all items demonstrating adequate internal construct validity. TBQ global score correlated with number of conditions (P = 0.034), EQ-5D-5L (P < 0.001), SF-6D (P < 0.001) and the feelings (P = 0.004), daily activities (P = 0.003) and social activities (P < 0.001) domains of the WONCA COOP. There was no significant correlation between global health rating and TBQ global scores (P = 0.298). Factor analysis demonstrated a three-factor structure. There was good internal consistency (Cronbach's alpha = 0.842) and good test-retest reliability (intra-class correlation coefficient = 0.830).
CONCLUSION: The newly translated Chinese version of the TBQ appears to be valid and reliable for use in Cantonese-speaking, adult primary care patients with multi-morbidity.
© The Author(s) 2019. Published by Oxford University Press. All rights reserved.For permissions, please e-mail: journals.permissions@oup.com.

Entities:  

Keywords:  Chronic disease; multi-morbidity; primary care; psychometrics; quality of care; quality of life

Mesh:

Year:  2019        PMID: 30820558     DOI: 10.1093/fampra/cmz008

Source DB:  PubMed          Journal:  Fam Pract        ISSN: 0263-2136            Impact factor:   2.267


  5 in total

1.  Translation, cultural adaptation and validation of the Chinese Multimorbidity Treatment Burden Questionnaire(C-MTBQ): a study of older hospital patients.

Authors:  Liyuan Dou; Juan Huang; Polly Duncan; Lixiang Guo
Journal:  Health Qual Life Outcomes       Date:  2020-06-22       Impact factor: 3.186

2.  Decreasing patient-reported burden of treatment: A systematic review of quantitative interventional studies.

Authors:  Aurore Lesage; Brice Leclère; Leïla Moret; Clément Le Glatin
Journal:  PLoS One       Date:  2021-01-12       Impact factor: 3.240

3.  A community-based nurse-led medication self-management intervention in the improvement of medication adherence in older patients with multimorbidity: protocol for a randomised controlled trial.

Authors:  Chen Yang; Zhaozhao Hui; Dejian Zeng; Song Zhu; Xiuhua Wang; Diana Tze Fan Lee; Sek Ying Chair
Journal:  BMC Geriatr       Date:  2021-03-02       Impact factor: 3.921

4.  Exploration of the psychometric properties of the Person-Centred Primary Care Measure (PCPCM) in a Chinese primary care population in Hong Kong: a cross-sectional validation study.

Authors:  Emily Tsui Yee Tse; Cindy Lo Kuen Lam; Carlos King Ho Wong; Weng Yee Chin; Rebecca S Etz; Stephen J Zyzanski; Kurt C Stange
Journal:  BMJ Open       Date:  2021-09-21       Impact factor: 2.692

5.  Development and preliminary validation of the competency model for rural general practitioner in China.

Authors:  Yun Wei; Yanli Liu; Xuexue Zhao; Guanghui Jin; Yali Zhao; Xiaoqin Lu
Journal:  Fam Pract       Date:  2021-06-17       Impact factor: 2.267

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.